Evidence map›Paper›PMID 35684404›Full record

ArticleMolecules (Basel, Switzerland)2022

New Coordination Compounds Based on a Pyrazine Derivative: Design, Characterization, and Biological Study.

Alina Climova, Ekaterina Pivovarova, Bartłomiej Rogalewicz, Anita Raducka, Małgorzata Szczesio, Izabela Korona-Głowniak, Agnieszka Korga-Plewko, Magdalena Iwan, Katarzyna Gobis, Agnieszka Czylkowska

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. A Review of the Biological Activity of Amidrazone Derivatives.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alina ClimovaInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego 116, 90-924 Lodz, Poland.ORCID 0000-0001-5249-9809
Ekaterina PivovarovaInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego 116, 90-924 Lodz, Poland.ORCID 0000-0001-8628-1568
Bartłomiej RogalewiczInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego 116, 90-924 Lodz, Poland.
Anita RaduckaInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego 116, 90-924 Lodz, Poland.
Małgorzata SzczesioInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego 116, 90-924 Lodz, Poland.
Izabela Korona-GłowniakDepartment of Pharmaceutical Microbiology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0003-1634-0387
Agnieszka Korga-PlewkoIndependent Medical Biology Unit, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland.ORCID 0000-0002-2027-9681
Magdalena IwanDepartment of Toxicology, Medical University of Lublin, Chodzki 6, 20-093 Lublin, Poland.ORCID 0000-0002-7834-0828
Katarzyna GobisDepartment of Organic Chemistry, Medical University of Gdansk, 107 Gen. Hallera Av., 80-438 Gdansk, Poland.ORCID 0000-0002-9856-9232
Agnieszka CzylkowskaInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego 116, 90-924 Lodz, Poland.ORCID 0000-0001-7157-5408

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New coordination compounds of Mn(II), Fe(III), Co(II), and Ni(II) and the biologically active ligand L (

Indexed as

Coordination ComplexesAnti-Bacterial AgentsCobaltCopperFerric CompoundsLigandsManganeseMicrobial Sensitivity TestsNickelPyrazinesAnti-Bacterial AgentsCobaltCoordination ComplexesCopperFerric CompoundsLigandsManganeseNickelPyrazinesantibacterialanticancerantifungalcobalt(II)drug designiron(III)LN229 cancer cellsmanganese(II)nickel(II)pyrazine derivativeU87 MG cancer cells

Identifiers

PMID35684404
PMCPMC9181841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.